News

BIO-SOURCING, CILOA AND INTRACT PHARMA LAUNCH €3.4M EU PROJECT IN INFLAMMATORY INDICATIONS WITH €1.9M SUBSIDIES FROM EUREKA EUROSTARS

28 May 2024

AB-BIOBETTER, led by Bio-Sourcing, to pioneer development of new oral formulation of adalimumab for inflammatory bowel diseases; offering patients less…

Ciloa will be presenting its disrupting co-agonist, Adiponectin, that boosts all GLP-1RA therapeutic effects on obesity/diabetes/MASH @Swiss Biotech Days 2024 (Basel, April 22-23)

15 April 2024

Ciloa, a preclinical stage French biotechnology company with a unique exosome bioengineering technology will attend the SwissBiotechDay 2024. Ciloa will be presenting…

Ciloa speaking @Bio-Europe Spring 2024 (Barcelona, March 18-20)

12 March 2024

Ciloa’s CEO, Robert Z. Mamoun will be speaking at Bio-Europe Spring 2024. If you’re Interested in therapies for Obesity, Diabetes,…

Ciloa @Innovative Therapies Days 2023 from 12 to 13 October (Besancon, France)

19 September 2023

Ciloa’s team will be pleased to be part and sponsor the 3rd Edition of the Innovative Therapy Days ! Come…

Ciloa @ISEV 2022 from 25 to 29 May (Lyon, France)

12 May 2022

Ciloa’s team will be pleased to present its last progress on extracellular vesicle (EV) editing and production. Come visit us…

Ciloa secures €5 million for biomedicines and vaccines development

8 March 2022

Ciloa secures €5 million for the development of its new generation of biomedicines and vaccines using exosomes The company finalized…